6 results match your criteria: "Hospital 'Bianchi Melacrino Morelli' Reggio Calabria[Affiliation]"
Am J Clin Oncol
March 2022
Breast Cancer Unit and Traslational Research Unit, ASST Cremona.
Introduction: In the current study, we have investigated the effects of the different modalities of treatment (volume of radiotherapy [RT], previous surgery) as well as the Gleason score of prostate cancer (PC) on the lymphocyte composition of PC patients undergoing RT.
Methods: This is a monoinstitutional study that prospectively included PC patients that underwent RT from January 2016 until December 2017. To compare the different evaluations, the Wilcoxon signed-rank test was used among 2 times (Timepoint 0 to Timepoint 1).
J Cardiovasc Echogr
April 2020
Cardiology Department, Hospital 'Bianchi Melacrino Morelli' Reggio Calabria, Italy.
Peripheral artery disease (PAD) and stroke can occur as vascular complication of anticancer treatment. Although the mechanisms, monitoring, and management of cardiotoxicities have received broad attention, vascular toxicities remain often underrecognized. In addition, the development of new chemotherapeutic drugs bears the risk of vasotoxicities that are yet to be identified and may not be realized with short-term follow-up periods.
View Article and Find Full Text PDFComplement Ther Clin Pract
May 2020
Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Background: Effectiveness of music-based interventions (Music therapy, MT) on cancer patients' is a current research theme. Oncology patients may respond to radiation treatment (RT) with anxiety expressed as stress, fear, depression, and frustration.
Objectives: The aim of this review is to discuss the effectiveness of MT in patients undergoing RT.
Oncol Lett
February 2020
Unit of Medical Oncology, Oncology Department, Grand Metropolitan Hospital 'Bianchi Melacrino Morelli' Reggio Calabria I-89124, Italy.
Immune checkpoint blockade is an emerging anticancer strategy, and Nivolumab is a human mAb to PD-1 that is used in the treatment of a number of different malignancies, including non-small cell lung cancer (NSCLC), kidney cancer, urothelial carcinoma and melanoma. Although the use of Nivolumab prolongs survival in a number of patients, this treatment is hampered by high cost. Therefore, the identification of predictive markers of response to treatment in patients is required.
View Article and Find Full Text PDFJ Cardiovasc Med (Hagerstown)
July 2019
Cardiology Department, University Hospital Policlinico Consorziale, Bari.
Strahlenther Onkol
August 2019
Sbarro Health Research Organization, Temple University, Philadelphia, PA, USA.
Aim: To assess the role of perilesional edema (PE) in non-small cell lung carcinoma (NSCLC) brain metastases (BM) undergoing radiosurgery (SRS).
Methods: This series includes 46 patients with 1-2 BM treated with SRS, selected out of all patients referred for radiotherapy (RT) for BMs over 5 years (2013 to 2017). Both the PE and gross tumor volume (GTV) were contoured on MRI images, and the PE/GTV ratio and PE + GTV value (TV, total volume) were calculated.